01 December 2021>: Articles
Unusual clinical courseJedediah J. Doane A* , Kellen S. Hirsch A , Justine O. Baldwin C , Mark M. Wurfel E , Sudhakar N. Pipavath C , T. Eoin West A
Am J Case Rep 2021; 22:e933458
Figure 1. Patient’s oxygen requirement throughout COVID-19-associated pulmonary fibrosis progression. Day 1 represents time at which a SARSCoV-2 nasopharyngeal PCR test was positive. Oxygen requirement quantified by liters per minute on either nasal cannula or high-flow nasal cannula. Data not shown include pressures during noninvasive positive-pressure ventilation and percent of oxygen delivered.